Angiosarcoma: a 10-year retrospective study from a high-volume UK regional referral centre.
Ahrin Anna MorrowJames HodsonCostanza FiguraSalena BainsRobert M WarnerL Max AlmondPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
RIAS is the most common AS subtype, with surgery the only potentially curative treatment modality. Overall prognosis varies significantly by subtype. An international consensus on classification of AS subtypes is required to allow meaningful comparisons across studies and/or a prospective multi-centre registry.